Global Ketorolac Injection Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Ketorolac Injection Market Research Report 2024
Ketorolac injection is used for the short-term treatment of moderate to severe pain. It is usually used before or after medical procedures or after surgery. Reducing pain helps you recover more comfortably so that you can return to your normal daily activities. This medication is a nonsteroidal anti-inflammatory drug.
According to Mr Accuracy reports’s new survey, global Ketorolac Injection market is projected to reach US$ 1125.6 million in 2034, increasing from US$ 939.8 million in 2022, with the CAGR of 2.7% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ketorolac Injection market research.
Global key ketorolac injection 核心厂商 Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma) etc. The top 2 companies hold a share about 20%. North America is the largest market, with a share about 40%, followed by Asia-Pacific and Europe with the share about 27% and 20%. In terms of product, 30mg/ml ketorolac injection is the largest segment, with a share over 64%. And in terms of application, the largest application is hospital, followed by clinics.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ketorolac Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Pfizer
Fresenius Kabi
Fosun Pharma (Gland Pharma)
Sagent Pharmaceuticals
Hikma
Lunan Pharma
Alvogen
Chengdu Brilliant Pharmaceuticals
Athenex
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
Tianjin Chase Sun Pharmaceutical
ZISKA Pharmaceuticals
Segment by Concentration
15mg/ml
30mg/ml
Hospital
Clinics
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Ketorolac Injection report covers below items
Chapter 1Product Basic Information (Definition, Concentration and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Concentration Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Ketorolac Injection market is projected to reach US$ 1125.6 million in 2034, increasing from US$ 939.8 million in 2022, with the CAGR of 2.7% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ketorolac Injection market research.
Global key ketorolac injection 核心厂商 Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma) etc. The top 2 companies hold a share about 20%. North America is the largest market, with a share about 40%, followed by Asia-Pacific and Europe with the share about 27% and 20%. In terms of product, 30mg/ml ketorolac injection is the largest segment, with a share over 64%. And in terms of application, the largest application is hospital, followed by clinics.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ketorolac Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Fresenius Kabi
Fosun Pharma (Gland Pharma)
Sagent Pharmaceuticals
Hikma
Lunan Pharma
Alvogen
Chengdu Brilliant Pharmaceuticals
Athenex
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
Tianjin Chase Sun Pharmaceutical
ZISKA Pharmaceuticals
Segment by Concentration
15mg/ml
30mg/ml
Segment by Application
Hospital
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Ketorolac Injection report covers below items
Chapter 1Product Basic Information (Definition, Concentration and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Concentration Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices